Eye scan could reveal best drug for schizophrenia
NCT ID NCT04986072
Summary
This study tested whether a non-invasive scan of the eye's blood vessels could predict which patients with early schizophrenia would respond to an intravenous drug called sodium nitroprusside. The drug was given to help reduce symptoms of psychosis and improve thinking. The goal was to find a biomarker to better match patients with treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.